Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland

Jarmo Oksi, A. Aalto, P. Saila, T. Partanen, Veli-Jukka A Anttila, E. Mattila

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalEuropean Journal of Clinical Microbiology & Infectious Diseases
Volume38
Issue number10
Pages (from-to)1947-1952
Number of pages6
ISSN0934-9723
DOIs
Publication statusPublished - Oct 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Clostridium difficile infection
  • Recurrence
  • Bezlotoxumab
  • RISK-FACTORS
  • VANCOMYCIN
  • METRONIDAZOLE
  • FIDAXOMICIN
  • OUTCOMES
  • THERAPY
  • DISEASE
  • 3121 Internal medicine
  • 1183 Plant biology, microbiology, virology

Cite this